GlassScriptPhysician profile
William S Coulter
NPI 1861654956
$1,863.05
in general payments reported to CMS, 2019-2025
12 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $38.72 · 2021: $34.61 · 2022: $97.65 · 2023: $1,490 · 2024: $45.28 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $878 · Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $877.92 |
| Food and Beverage | $814.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,422.00 | 2023 | Alphavac, Nanoknife |
| Terumo Medical Corporation | $145.47 | 2020-2023 | Azur Cx Detachable |
| Penumbra, INC. | $99.10 | 2024-2025 | Penumbra System, Ruby Coil |
| Boston Scientific Corporation | $35.67 | 2022 | |
| Urogen Pharma, INC. | $27.46 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $23.25 | 2022 | |
| Stryker Corporation | $21.21 | 2025 | Flowtriever |
| Takeda Pharmaceuticals U.S.A., INC. | $20.00 | 2025 | Eohilia |
| Karl Storz Endoscopy-America | $19.86 | 2025 | |
| Abbott Laboratories | $19.05 | 2021 | |
| Depuy Synthes Sales INC. | $15.97 | 2023 | Confidence Spinal Cement System |
| Advanced Critical Devices, INC. | $14.01 | 2025 | Vascular Products |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Coulter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.